SOTHEMA (CAS:SOT) ROCE %: 25.42% (As of Dec. 2025)


CAS:SOT SOTHEMA CAS:SOT
75 GF Score
Price MAD379.95
GF Value MAD284.83
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is SOTHEMA ROCE %?

SOTHEMA CAS:SOT +1.05% 75 ROCE % is 25.42% as of Dec. 2025. GuruFocus rates CAS:SOT with a GF Score™ of 75/100 and a GF Value™ of MAD284.83 (Significantly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SOTHEMA's annualized ROCE % for the quarter that ended in Dec. 2025 was 25.42%.

SOTHEMA  (CAS:SOT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SOTHEMA ROCE % Related Terms

SOTHEMA ROCE % Historical Data

* Premium members only.

The historical data trend for SOTHEMA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOTHEMA ROCE % Chart

SOTHEMA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.77 27.69 23.69 27.69 24.92

SOTHEMA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.31 27.99 28.91 31.00 25.42
CAS:SOT
75GF Score
SOTHEMA CAS:SOT
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SOTHEMA ROCE % Calculation

SOTHEMA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=648.802/( ( (3182.052 - 1175.592) + (4607.253 - 1406.926) )/ 2 )
=648.802/( (2006.46+3200.327)/ 2 )
=648.802/2603.3935
=24.92 %

SOTHEMA's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=668.03/( ( (3327.847 - 1271.894) + (4607.253 - 1406.926) )/ 2 )
=668.03/( ( 2055.953 + 3200.327 )/ 2 )
=668.03/2628.14
=25.42 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 25.42% mean?
SOTHEMA (CAS:SOT) has a ROCE % of 25.42% as of Dec. 2025.
Is SOTHEMA's ROCE % too high?
SOTHEMA's current ROCE % is 25.42%. The Drug Manufacturers industry median ROCE % is 7.00. SOTHEMA's value of 25.42% is 263.4% above this industry median. Overall, SOTHEMA has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOTHEMA's ROCE % compare to LLY and JNJ?
SOTHEMA's ROCE % of 25.42% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. SOTHEMA's value of 25.42% is 263.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SOTHEMA's current ROCE % of 25.42% is 263.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOTHEMA's current ROCE % is 25.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOTHEMA stock overvalued right now?
Based on GuruFocus' analysis, SOTHEMA (CAS:SOT) is currently considered Significantly Overvalued. The stock's GF Value™ is MAD284.83, compared to a current price of MAD379.95 — trading 33.4% above its estimated fair value. The current ROCE % is 25.42% and 263.4% above the Drug Manufacturers industry median of 7.00. SOTHEMA's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For SOTHEMA (CAS:SOT), the current ROCE % is 25.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SOTHEMA (CAS:SOT) Overvalued in 2026?

Based on GuruFocus' analysis, SOTHEMA stock appears to be overvalued. The current stock price of MAD379.95 is trading 33.4% above its estimated GF Value™ of MAD284.83. GuruFocus considers SOTHEMA to be Significantly Overvalued.

Key valuation signals for CAS:SOT:

  • ROCE %: 25.42%
  • GF Value™: MAD284.83 vs. price of MAD379.95 (33.4% above fair value)
  • GF Score™: 75/100 with 6 warning signs
  • Industry Position: 263.4% above the Drug Manufacturers median

No single metric tells the full story. See the CAS:SOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SOTHEMA Business Description

Address Centre de Bouskoura, BP no. 1, Casablanca, MAR
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
75GF Score

Get the complete analysis for CAS:SOT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD379.95
Price
MAD284.83
GF Value